The DOI matches its Crossref record; 315 of the 315 references it cites were found in a registry or an index.
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Open accessAbstract
The review aims to consolidate research findings on the molecular mechanisms and virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and their relevance to four typical stages in the development of acute viral infection. These four stages are invasion; primary blockade of antiviral innate immunity; engagement of the virus’s protection mechanisms against the factors of adaptive immunity; and acute, long-term complications of COVID-19. The invasion stage entails the recognition of the spike protein (S) of SARS-CoV-2 target cell receptors, namely, the main receptor (angiotensin-converting enzyme 2, ACE2), its coreceptors, and potential alternative receptors. The presence of a diverse repertoire of receptors allows SARS-CoV-2 to infect various types of cells, including those not expressing ACE2. During the second stage, the majority of the polyfunctional structural, non-structural, and extra proteins SARS-CoV-2 synthesizes in infected cells are involved in the primary blockage of antiviral innate immunity. A high degree of redundancy and systemic action characterizing these pathogenic factors allows SARS-CoV-2 to overcome antiviral mechanisms at the initial stages of invasion. The third stage includes passive and active protection of the virus from factors of adaptive immunity, overcoming of the barrier function at the focus of inflammation, and generalization of SARS-CoV-2 in the body. The fourth stage is associated with the deployment of variants of acute and long-term complications of COVID-19. SARS-CoV-2’s ability to induce autoimmune and autoinflammatory pathways of tissue invasion and development of both immunosuppressive and hyperergic mechanisms of systemic inflammation is critical at this stage of infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–315 of 315
Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons
Lucchese, G., & Flöel, A. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102556 · Cited by 109
Role of host factors in SARS-CoV-2 entry
Evans, J. P., & Liu, S. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100847 · Cited by 109
Persistent SARS-2 infections contribute to long COVID-19
Jacobs, J. J. L. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110538 · Cited by 105
Gonzalez–Gronow, M., Gopal, U., Austin, R. C., & Pizzo, S. V. (2021) · IUBMB Life · doi:10.1002/iub.2502 · Cited by 104
SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
Fenizia, C., Galbiati, S., Vanetti, C., Vago, R., Clerici, M., Tacchetti, C., & Daniele, T. (2021) · Cells · doi:10.3390/cells10061434 · Cited by 103
Acute Infection of Viral Pathogens and Their Innate Immune Escape
Rai, K. R., Shrestha, P., Yang, B., Chen, Y., Liu, S., Maarouf, M., & Chen, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.672026 · Cited by 102
Dyer, O. (2021) · BMJ · doi:10.1136/bmj.n3104 · Cited by 102
Vink, M., & Vink-Niese, A. (2020) · Healthcare · doi:10.3390/healthcare8040552 · Cited by 100
Immunobiology and immunotherapy of COVID‐19: A clinically updated overview
Esmaeilzadeh, A., & Elahi, R. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30076 · Cited by 99
Kyrou, I., Randeva, H. S., Spandidos, D. A., & Karteris, E. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00460-9 · Cited by 99
Bhattacharya, M., Sharma, A. R., Mallick, B., Sharma, G., Lee, S., & Chakraborty, C. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104587 · Cited by 98
Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital
Chauvineau‐Grenier, A., Bastard, P., Servajean, A., Gervais, A., Rosain, J., Jouanguy, E., Cobat, A., Casanova, J., & Rossi, B. (2022) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01203-3 · Cited by 98
Long‐term coexistence of SARS‐CoV‐2 with antibody response in COVID‐19 patients
Wang, B., Wang, L., Kong, X., Geng, J., Xiao, D., Ma, C., Jiang, X., & Wang, P. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25946 · Cited by 97
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
Khosroshahi, L. M., Rokni, M., Mokhtari, T., & Noorbakhsh, F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107364 · Cited by 94
SARS-CoV-2 Envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein ZO1
Shepley‐McTaggart, A., Sagum, C. A., Oliva, I. B., Rybakovsky, E., DiGuilio, K., Liang, J., Bedford, M. T., Cassel, J. A., Sudol, M., Mullin, J. M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251955 · Cited by 90
On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity
Elrashdy, F., Aljaddawi, A. A., Redwan, E. M. M. M., & Uversky, V. N. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1790426 · Cited by 89
Gupta, M., Azumaya, C. M., Moritz, M., Pourmal, S., Diallo, A., Merz, G. E., Jang, G., Bouhaddou, M., Fossati, A., Brilot, A. F., et al. (2021) · doi:10.1101/2021.05.10.443524 · Cited by 89
Prabhakara, C., Godbole, R. K., Sil, P., Jahnavi, S., Gulzar, S.-E.-J., van Zanten, T. S., Sheth, D., Subhash, N., Chandra, A., Shivaraj, A., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009706 · Cited by 88
Goh, G. K., Dunker, A. K., Foster, J. A., & Uversky, V. N. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104177 · Cited by 87
Epitope Spreading: A Mechanism for Progression of Autoimmune Disease
Tuohy, V. K., & Kinkel, R. P. (2001) · Springer eBooks · doi:10.1007/978-94-010-0981-2_4 · Cited by 85
Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression
Nakagawa, K., & Makino, S. (2021) · Cells · doi:10.3390/cells10020300 · Cited by 85
SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential
Vithani, N., Ward, M. D., Zimmerman, M. I., Novak, B., Borowsky, J. H., Singh, S., & Bowman, G. R. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.03.024 · Cited by 84 · cited 1×
“(IFNAR1) and induces ER stress (shown in SARS‐CoV‐1) [185,186].”
BackgroundKumar, R., Verma, H., Singhvi, N., Sood, U., Gupta, V., Singh, M., KUMARI, R. R., Hira, P., Nagar, S., Talwar, C., et al. (2020) · mSystems · doi:10.1128/msystems.00505-20 · Cited by 84
Apoptosis‐induced T‐cell lymphopenia is related to COVID‐19 severity
Çizmecioğlu, A., Çizmecioğlu, H. A., Göktepe, M. H., Emsen, A., Korkmaz, C., Taşbent, F. E., Çölkesen, F., & Artaç, H. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26742 · Cited by 84
The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans
Pancer, K., Milewska, A., Owczarek, K., Dabrowska, A., Kowalski, M., Łabaj, P. P., Branicki, W., Sanak, M., & Pyrc, K. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008959 · Cited by 83
COVID-19: fighting the invisible enemy with microRNAs
Chauhan, N., Jaggi, M., Chauhan, S. C., & Yallapu, M. M. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1812385 · Cited by 82
Why do SARS-CoV-2 NSPs rush to the ER?
Santerre, M., Arjona, S. P., Allen, C. N. S., Shcherbik, N., & Sawaya, B. E. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10197-8 · Cited by 82
Epithelial response to IFN‐γ promotes SARS‐CoV‐2 infection
Heuberger, J., Trimpert, J., Vladimirova, D., Goosmann, C., Lin, M., Schmuck, R. B., Mollenkopf, H., Brinkmann, V., Tacke, F., Osterrieder, N., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013191 · Cited by 82
The potential role of neopterin in Covid-19: a new perspective
Al-Kuraishy, H. M., Al-Gareeb, A. I., Alzahrani, K. J., Martins, N. A., & Batiha, G. E. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04232-z · Cited by 81
Two conserved oligomer interfaces of NSP7 and NSP8 underpin the dynamic assembly of SARS-CoV-2 RdRP
Biswal, M. N., Diggs, S., Xu, D., Khudaverdyan, N., Lu, J., Fang, J., Blaha, G. M., Hai, R., & Song, J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab370 · Cited by 79
Case, J. B., Ashbrook, A. W., Dermody, T. S., & Denison, M. R. (2016) · Journal of Virology · doi:10.1128/jvi.00542-16 · Cited by 76
The human coronaviruses (HCoVs) and the molecular mechanisms of SARS-CoV-2 infection
Santacroce, L., Charitos, I. A., Carretta, D. M., Nitto, E. D., & Lovero, R. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-02012-8 · Cited by 76
Gan, H. H., Twaddle, A., Marchand, B., & Gunsalus, K. C. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167051 · Cited by 76
Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections
Abu‐Izneid, T., Alhajri, N., Ibrahim, A. M., Javed, M. N., Fahelelbom, K. M., Pottoo, F. H., & Kamal, M. A. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.11.013 · Cited by 75
Canonical and Noncanonical Autophagy as Potential Targets for COVID-19
Belló-Pérez, M., Sola, I., Novoa, B., Klionsky, D. J., & Falcó, A. (2020) · Cells · doi:10.3390/cells9071619 · Cited by 72
McClain, M. T., Park, L. P., Nicholson, B. P., Veldman, T., Zaas, A. K., Turner, R., Lambkin‐Williams, R., Gilbert, A. S., Ginsburg, G. S., & Woods, C. W. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.09.015 · Cited by 71
Elrashdy, F., Redwan, E. M. M. M., & Uversky, V. N. (2020) · Biomolecules · doi:10.3390/biom10091312 · Cited by 71
Cellular Stress and General Pathological Processes
Gusev, E. Y., & Zotova, N. V. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190319114641 · Cited by 69
Self-citationHoushmandfar, S., Saeedi‐Boroujeni, A., Rashno, M. M., Khodadadi, A., & Mahmoudian‐Sani, M. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02163-6 · Cited by 69
Gurunathan, S., Kang, M.-H., & Kim, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716407 · Cited by 68
Okamoto, M., Tsukamoto, H., Kouwaki, T., Seya, T., & Oshiumi, H. (2017) · Viral Immunology · doi:10.1089/vim.2016.0178 · Cited by 67
Hopkins, C. L., Lechien, J. R., & Saussez, S. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110406 · Cited by 67
Classical and alternative receptors for SARS‐CoV‐2 therapeutic strategy
Masre, S. F., Jufri, N. F., Ibrahim, F. W., & Raub, S. H. A. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2207 · Cited by 67
Shang, C., Zhuang, X., Zhang, H., Li, Y., Zhu, Y., Lu, J., Ge, C., Cong, J., Li, T., Tian, M., et al. (2021) · Virology Journal · doi:10.1186/s12985-021-01515-1 · Cited by 67
Bükülmez, H. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-021-01028-4 · Cited by 65
An updated analysis of variations in SARS-CoV-2 genome
Uğurel, O. M., Ata, O., & Turgut‐Balik, D. (2020) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2005-111 · Cited by 63
Alam, S. B., Willows, S. D., Kulka, M., & Sandhu, J. K. (2020) · European Journal of Neurology · doi:10.1111/ene.14442 · Cited by 63
Loss of orf3b in the circulating SARS-CoV-2 strains
Lam, J.-Y., Yuen, C., Ip, J. D., Wong, W., To, K. K., Yuen, K., & Kok, K. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1852892 · Cited by 63
The interplay between emerging human coronavirus infections and autophagy
Zhao, Z., Lu, K., Mao, B., Liu, S., Trilling, M., Huang, A., Lu, M., & Lin, Y. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1872353 · Cited by 63
Verkhivker, G. M. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00654 · Cited by 61
Mutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load
Eskier, D., Süner, A., Oktay, Y., & Karakülah, G. (2020) · PeerJ · doi:10.7717/peerj.10181 · Cited by 60
Cheng, M. H., Porritt, R. A., Rivas, M. N., Krieger, J., Ozdemir, A. B., Garcia, G., Arumugaswami, V., Fries, B. C., Arditi, M., & Bahar, İ. (2021) · Structure · doi:10.1016/j.str.2021.04.005 · Cited by 60
Pandey, P., Prasad, K., Prakash, A., & Kumar, V. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01980-1 · Cited by 59
SARS-CoV-2 triggers DNA damage response in Vero E6 cells
Victor, J., Deutsch, J., Whitaker, A., Lamkin, E. N., March, A., Zhou, P., Botten, J., & Chatterjee, N. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.09.024 · Cited by 59
Rokni, M., Ahmadikia, K., Asghari, S., Mashaei, S., & Hassanali, F. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05540-3 · Cited by 58
Follow-up of COVID-19 recovered patients with mild disease
Kashif, A., Chaudhry, M., Fayyaz, T., Abdullah, M., Malik, A. I., Anwer, J. M. A., Inam, S. H. A., Fatima, T., Iqbal, N., & Shoaib, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-92717-8 · Cited by 58
Ward, J. D., Cornaby, C., & Schmitz, J. L. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00811-21 · Cited by 58
MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?
Abedi, F., Rezaee, R., Hayes, A. W., Nasiripour, S., & Karimi, G. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1867792 · Cited by 56
Huang, S., & Wang, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063060 · Cited by 56
SARS-CoV-2 Molecular Network Structure
Díaz, J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00870 · Cited by 55
Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2
Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., Uversky, V. N., Aljabali, A. A. A., Lundstrom, K. H., Uhal, B. D., Rezaei, N., Seyran, M., et al. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.03.199 · Cited by 53
van Laarhoven, A., Kurver, L., Overheul, G. J., Kooistra, E. J., Abdo, W. F., van Crevel, R., Duivenvoorden, R., Kox, M., ten Oever, J., Schouten, J. A., et al. (2021) · Med · doi:10.1016/j.medj.2021.09.003 · Cited by 51
Structure and Function of N-Terminal Zinc Finger Domain of SARS-CoV-2 NSP2
Ma, J., Chen, Y., Wu, W., & Chen, Z. (2021) · Virologica Sinica · doi:10.1007/s12250-021-00431-6 · Cited by 50
Gusev, E., Sarapultsev, A., Hu, D., & Черешнев, В. А. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147582 · Cited by 48
Self-citationEmerging roles of extracellular vesicles in COVID‐19, a double‐edged sword?
Xia, X., Yuan, P., Liu, Y., Wang, Y., Cao, W., & Zheng, J. (2021) · Immunology · doi:10.1111/imm.13329 · Cited by 47
Khoshkam, Z., Aftabı, Y., Stenvinkel, P., Lawrence, B. P., Habibi-Rezaei, M., Ichihara, G., & Fereidouni, S. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2020.12.013 · Cited by 46
Pinheiro, M. M., Fabbri, A., & Infante, M. (2021) · Immunotherapy · doi:10.2217/imt-2020-0349 · Cited by 46
Viral strategies for circumventing p53: the case of severe acute respiratory syndrome coronavirus
Cardozo, C. M., & Hainaut, P. L. (2021) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000713 · Cited by 45
Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learnt
Dhawan, M. K., Priyanka, & Choudhary, O. P. (2021) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.106198 · Cited by 45
Haroun, R. A., Osman, W. H., & Eessa, A. M. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119019 · Cited by 44
Brandherm, L., Kobaš, A. M., Klöhn, M., Brüggemann, Y., Pfaender, S., Rassow, J., & Kreimendahl, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179233 · Cited by 43
Liu, T., Jia, P., Fang, B., & Zhao, Z. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.603509 · Cited by 42
Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology
Haas, P., Muralidharan, M., Krogan, N. J., Kaake, R. M., & Hüttenhain, R. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00764 · Cited by 42
Mahalapbutr, P., Kongtaworn, N., & Rungrotmongkol, T. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.09.032 · Cited by 41
The intersection of COVID-19 and autoimmunity: What is our current understanding?
Winchester, N., Calabrese, C. M., & Calabrese, L. H. (2021) · Pathogens and Immunity · doi:10.20411/pai.v6i1.417 · Cited by 41
Zheng, Y.-X., Wang, L., Kong, W.-S., Chen, H., Wang, X., Meng, Q., Zhang, H., Guo, S., Jiang, H., & Tao, S. (2021) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmab088 · Cited by 41
Lokhande, K. B., Apte, G. R., Shrivastava, A., Singh, A., Pal, J. K., Swamy, K. V., & Gupta, R. K. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1851303 · Cited by 39
ORF10–Cullin-2–ZYG11B complex is not required for SARS-CoV-2 infection
Mena, E. L., Donahue, C. J., Vaites, L. P., Li, J., Róna, G., O’Leary, C., Lignitto, L., Miwatani-Minter, B., Paulo, J. A., Dhabaria, A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2023157118 · Cited by 39
A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics
Verma, J. K., & Subbarao, N. (2021) · Archives of Virology · doi:10.1007/s00705-021-04961-y · Cited by 36
The Antiviral Apparatus: STING and Oncolytic Virus Restriction
Lee, J., Ghonime, M. G., Wang, R., & Cassady, K. A. (2019) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2019.02.002 · Cited by 35
DPP4 Inhibitors and COVID-19–Holy Grail or Another Dead End?
Krejner‐Bienias, A., Grzela, K., & Grzela, T. (2021) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-020-00602-5 · Cited by 35
Editorial: Microbial and Environmental Factors in Autoimmune and Inflammatory Diseases
Arleevskaya, M. I., Manukyan, G. P., Inoüe, R., & Aminov, R. I. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00243 · Cited by 33
Ye, X., Xiao, X., Li, B., Zhu, W., Li, Y., Wu, J., Huang, X., Jin, J., Chen, D., Jin, J., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01272 · Cited by 33
Scaglioni, V., & Soriano, E. R. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12944 · Cited by 33
Mattiuzzi, C., Henry, B. M., Sanchis‐Gomar, F., & Lippi, G. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i3.10303 · Cited by 32
Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality
Mdkhana, B., Sharif‐Askari, N. S., Ramakrishnan, R. K., Goel, S., Hamid, Q. A., & Halwani, R. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s277716 · Cited by 32
Physiological and pathogenic role of scavenger receptors in humans
Gusev, E., Zotova, N. V., Zhuravleva, Y. A., & Черешнев, В. А. (2020) · Medical Immunology (Russia) · doi:10.15789/1563-0625-pap-1893 · Cited by 31
Self-citationHomology between SARS CoV-2 and human proteins
Khavinson, V. K., Terekhov, A., Кормилец, Д. Ю., & Maryanovich, A. T. (2021) · Scientific Reports · doi:10.1038/s41598-021-96233-7 · Cited by 31
Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing
Rea, I. M., & Alexander, H. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101494 · Cited by 29
Structural Variability in the RLR-MAVS Pathway and Sensitive Detection of Viral RNAs
Jiang, Q. (2018) · Medicinal Chemistry · doi:10.2174/1573406415666181219101613 · Cited by 27
Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis
Danladi, J., & Sabir, H. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577632 · Cited by 27
Brehm, T. T., Pfefferle, S., von Possel, R., Kobbe, R., Nörz, D. S., Schmiedel, S., Grundhoff, A. T., Olearo, F., Emmerich, P., Robitaille, A., et al. (2021) · Viruses · doi:10.3390/v13040661 · Cited by 26
Kunkl, M., Amormino, C., Caristi, S., Tedeschi, V., Fiorillo, M. T., Levy, R., Popugailo, A., Kaempfer, R. O. R., & Tuosto, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.723689 · Cited by 26
Reinfections in COVID-19 Patients: Impact of Virus Genetic Variability and Host Immunity
Fakhroo, A. D., Al-Khatib, H. A., Thani, A. A. A., & Yassine, H. M. (2021) · Vaccines · doi:10.3390/vaccines9101168 · Cited by 26
Systemic Glycosaminoglycan Clearance by HARE/Stabilin-2 Activates Intracellular Signaling
Weigel, P. H. (2020) · Cells · doi:10.3390/cells9112366 · Cited by 25
Renner, K., Schwittay, T., Chaabane, S., Gottschling, J., Müller, C., Tiefenböck, C., Salewski, J.-N., Winter, F., Buchtler, S., Balam, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23334-2 · Cited by 25
Zhang, W., Ma, Z., Wu, Y., Shi, X., Zhang, Y., Zhang, M., Zhang, M., Wang, L., & Liu, W. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155697 · Cited by 25
Tangye, S. G., Bucciol, G., & Meyts, I. (2021) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000786 · Cited by 24
Inflammatory endotypes of CRSwNP and responses to COVID-19
Wang, M., Wang, C., & Zhang, L. (2020) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000700 · Cited by 23
Shoaib, M. H., Ahmed, F. R., Sikandar, M., Yousuf, R. I., & Saleem, M. T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.576448 · Cited by 23
Nizamudeen, Z. A., Xu, E.-R., Karthik, V., Halawa, M. R., Arkill, K. P., Jackson, A. M., Bates, D. O., & Emsley, J. (2020) · Bioscience Reports · doi:10.1042/bsr20203837 · Cited by 22
Tan, Y., Schneider, T., Shukla, P., Chandrasekharan, M. B., Aravind, L., & Zhang, D. (2021) · Virus Evolution · doi:10.1093/ve/veab014 · Cited by 21
Molecular detection of SARS-CoV-2 being challenged by virus variation and asymptomatic infection
Jiang, C., Li, X., Ge, C., Ding, Y., Zhang, T., Cao, S., Meng, L., & Lu, S. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.03.006 · Cited by 21
Wang, H., Zhang, Z., Zhou, J., Han, S., Kang, Z., Chuang, H.-Y., Fan, H., Zhao, H., Wang, L., Ning, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.782731 · Cited by 20
Self-citationCorrelation of the Evolution of Immunity and Inflammation in Vertebrates
Gusev, E. Y., Zhuravleva, Y. A., & Zotova, N. V. (2019) · Biology Bulletin Reviews · doi:10.1134/s2079086419040029 · Cited by 19
Self-citationLandscape of SARS-CoV-2 spike protein-interacting cells in human tissues
Zheng, B., Yuan, M., Ma, Q., Wang, S., Tan, Y., Xu, Y., Ye, J., Gao, Y., Sun, X., Yang, Z., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107567 · Cited by 19
Aldaais, E. A., Yegnaswamy, S., Albahrani, F., Alsowaiket, F., & Alramadan, S. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101023 · Cited by 17
Abe, H., Satoh, J., Shirasaka, Y., Kogure, A., Kato, H., Ito, S., & Fujita, T. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00509-19 · Cited by 16
Structural biology of coronavirus ion channels
Barrantes, F. J. (2021) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798321001431 · Cited by 16
Is There any Alternative Receptor for SARS-CoV-2?
Felordi, M. S., Memarnejadian, A., Najimi, M., & Vosough, M. (2021) · PubMed · doi:10.22074/cellj.2021.7977 · Cited by 16
Collins, D. P., & Steer, C. J. (2021) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s301979 · Cited by 15
Elfiky, A. A., Ibrahim, I. M., Amin, F. G., Ismail, A. M., & Elshemey, W. M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-63761-3_10 · Cited by 12
Neutralizing Anti-interferon-γ Autoantibodies: an Ameliorating Factor in COVID-19 Infection?
Kačar, M., Cortes-Acevedo, P., Patel, V., Carter, C. R. D., Hughes, P. J., McGann, H., Gkrania‐Klotsas, E., Baxendale, H., Barcenas‐Morales, G., Döffinger, R., et al. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01102-7 · Cited by 8
Dembrovszky, F., Váncsa, S., Farkas, N., Erőss, B. M., Szakó, L., Teutsch, B., Bunduc, Ș., Nagy, R., Dohos, D., Kiss, S., et al. (2021) · Viruses · doi:10.3390/v13050809 · Cited by 5
Cited by
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Gusev, E., & Sarapultsev, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097910 · Cited by 312
Self-citationHost-directed immunotherapy of viral and bacterial infections: past, present and future
Wallis, R. S., O’Garra, A., Sher, A., & Wack, A. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00734-z · Cited by 255
Metadata
- Authors
- Gusev, E., Sarapultsev, A., Solomatina, L., & Chereshnev, V.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-02-02
- Volume
- 23
- Issue
- 3
- Pages
- 1716
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4210457246
- Cited by
- 281
- References
- 315
- FWCI
- 29.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.